Northport Dialysis is a medicare approved dialysis facility center in Northport, Alabama and it has 14 dialysis stations. It is located in Tuscaloosa county at 2401 Hospital Drive, Northport, AL, 35476. You can reach out to the office of Northport Dialysis at (205) 339-8882. This dialysis clinic is managed and/or owned by Davita. Northport Dialysis has the following ownership type - Profit. It was first certified by medicare in December, 1996. The medicare id for this facility is 012570 and it accepts patients under medicare ESRD program.
| Name | Northport Dialysis |
|---|---|
| Location | 2401 Hospital Drive, Northport, Alabama |
| No. of Dialysis Stations | 14 |
| Medicare ID | 012570 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 2401 Hospital Drive, Northport, Alabama, 35476 | |
| (205) 339-8882 | |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago
| NPI Number | 1336112598 |
| Organization Name | Northport Dialysis |
| Doing Business As | Dva Healthcare Renal Care Inc |
| Address | 2401 Hospital Dr Northport, Alabama, 35476 |
| Phone Number | (205) 339-8882 |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago
| Dialysis patients with Hemoglobin data | 45 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 27 |
| Medicare patients who had average hemoglobin (hgb) greater than 12 g/dL | 2 |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 84 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 693 |
| Percentage of adult patients getting regular hemodialysis at the center | 94 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Northport Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 87 |
| Hypercalcemia patient months | 712 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 95 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 20 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 32 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
| Patients with Serumphosphor greater than 7 mg/dL | 19 |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 82 |
| Patient months included in arterial venous fistula and catheter summaries | 573 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 51 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 14 |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 75 |
| Hospitalization Rate in facility | 430.9 (Worse than Expected) |
| Hospitalization Rate: Upper Confidence Limit | 619.9 |
| Hospitalization Rate: Lower Confidence Limit | 305.5 |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago
The rate of readmission show you whether patients who were being treated regularly at Northport Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 37.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 47.1 |
| Readmission Rate: Lower Confidence Limit | 28.9 |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Northport Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 2.88 (Worse than Expected) |
| SIR: Upper Confidence Limit | 4.89 |
| SIR: Lower Confidence Limit | 1.56 |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Northport Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 69 |
| Transfusion Rate in facility | 94.2 (Worse than Expected) |
| Transfusion Rate: Upper Confidence Limit | 174.2 |
| Transfusion Rate: Lower Confidence Limit | 54.9 |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago
The rate of mortality show you whether patients who were being treated regularly at Northport Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 313 |
| Mortality Rate in facility | 34.7 (Worse than Expected) |
| Mortality Rate: Upper Confidence Limit | 44.3 |
| Mortality Rate: Lower Confidence Limit | 26.6 |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to treat HIV.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
› Verified 3 days ago